Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers.
Journal: Human psychopharmacology
Published: February 28, 2023
A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.
Journal: Journal of opioid management
Published: January 07, 2017
GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans.
Journal: Psychopharmacology
Published: August 11, 2016
Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 18, 2016
Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate response.
Journal: United European gastroenterology journal
Published: November 05, 2015
AZD6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers.
Journal: Journal of clinical psychopharmacology
Published: December 11, 2014
Naloxegol for opioid-induced constipation in patients with noncancer pain.
Journal: The New England journal of medicine
Published: June 05, 2014
Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
Journal: Alimentary pharmacology & therapeutics
Published: May 28, 2014
The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.
Journal: Clinical pharmacology in drug development
Published: February 05, 2014
The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.
Journal: British journal of clinical pharmacology
Published: October 11, 2013
Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT/QTc study in healthy volunteers.
Journal: Clinical therapeutics
Published: June 17, 2013
Last Updated: 09/26/2026